China Resources Double-Crane Pharmaceutical's (SHA:600062) unit, Anhui Shuanghe Pharmaceutical, plans to build a new industrial park for 1.48 billion yuan, according to a Shanghai Stock Exchange disclosure on Wednesday.
The construction is part of Anhui Shuanghe's plan to relocate its Sanshan production base to Fanchang District, Wuhu City, China. Construction will begin in February and production will start in January 2028.
The planned industrial park will produce 1.15 billion bottles every year, the pharmaceutical company said.
The company's shares fell 2% in recent trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.